Business Type
- Distributor
- Exporter
- Importer
- Manufacturer
- Supplier
Certifications
- ANSI
- FDA Approved
- ISO
Company Overview
The Multidisciplinary Association for Psychedelic Studies (MAPS) is a membership - based, IRS - approved 501 (c) (3) non - profit research and educational organization. We assist scientists to design, fund, obtain approval for and report on studies into the risks and benefits of MDMA, psychedelic drugs and marijuana. MAPS' mission is to sponsor scientific research designed to develop psychedelics and marijuana into FDA - approved prescription medicines, and to educate the public honestly about the risks and benefits of these drugs. Read our strategy statement for more information. We need your support so together we can make a difference. In addition to general membership donations, MAPS is seeking to raise funds for specific research projects. These are our funding priorities and here are our financial reports.
Company Images
 |  |  |  |
 |  |  |  |
Areas of Expertise
General, Levels, Lead, Cases, Felt, Training, Plants, Compounds, Office Supplies, Acetic Acid, Data Management, Drug Delivery Devices, Signs, Internet, Financial, Data Acquisition, Office Equipment, Elements, Measurement, Supports, Scales, Hydrochloric Acid, Environmental, Inhibitors, Image Analysis Software, Equipment, Software, Film, Speakers, Colors, Maintenance, Markers, Glass, Medical Monitors, Blocks,
Products & Services
ayahuasca, cluster headaches, drugs, ecstasy, harm reduction, ibogaine, marijuana, mdma, mdma drug policy reform, medical marijuana, mescaline, multidisciplinary association for psychedelic studies, peyote, psilocybin, psychedelics, ptsd, salvia divinorum, terminal cancer anxiety, war on drugs, maps,
Company News ( via Twitter )
- #Video: Ethical Considerations in the Medicinal Use of #Psychedelics -- Julie Holland, M.D. http://t.co/Af4PL0OKOV #science #health
- #Video: #Psilocybin in the Treatment of #Smoking #Addiction: Psychological Mechanisms and Participant Account http://t.co/Yw1Dev3Coo
- New study results indicate that #marijuana use is associated with lower levels of fasting insulin. http://t.co/OGIyhUfw1H #diabetes
- #Video: Dennis McKenna speaks at #Psychedelic #Science 2013 about admixture plants used to make #ayahuasca. http://t.co/IM2V8PR5eI
- On 4/17/13, the 1st subject was treated in our new Israeli study of #MDMA-assisted psychotherapy for #PTSD. http://t.co/rykKE5t1jQ #Israel
- Research shows that #ketamine may have potential benefits for people suffering from treatment-resistant #depression. http://t.co/jJqNcaifpW
- The design for our study of #MDMA-assisted #therapy for #social #anxiety in #autistic adults was approved by the FDA. http://t.co/ZjdZB4MgGr
- All-new clinical studies. Unprecedented media coverage. The evidence is clear: we are transforming medicine. http://t.co/1P8GIQZx4L
